Central control of peripheral circulating somatostatin in dogs: effect of 2-deoxyglucose.

Circulating plasma somatostatin concentrations are known to fluctuate in response to nutrients and hormones. However, little is known about neural or central nervous system (CNS) control of somatostatin secretion. To test whether peripheral circulating somatostatin is influenced by a central stimulus, 2-deoxyglucose (37.5 mg/kg) was infused into a lateral cerebral ventricle of six conscious dogs over a period of 15 min. Plasma somatostatin levels rose from a base line of 105 +/- 6 pg/ml (mean +/- SE) to a peak of 154 +/- 10 pg/ml (P less than 0.005) at 30 min after the onset of the infusion. Somatostatin levels were still significantly elevated (P less than 0.025) at 60 min (119 +/- 6 pg/ml) and thereafter gradually returned toward base line. Plasma glucose and glucagon levels increased in response to intraventricular 2-deoxyglucose. Glucose concentrations rose from 105 +/- 5 mg/dl to peak at 203 +/- 16 mg/dl (P less than 0.005) at 80 min and remained elevated to 120 min. The concentration of plasma glucagon increased from 41 +/- 6 to 92 +/- 18 pg/ml at 60 min (P less than 0.05) and then declined. In marked contrast to intraventricular 2-deoxyglucose, similar concentrations of 2-deoxyglucose administered intravenously (n = 4) resulted in a slight fall in plasma somatostatin. Intraventricular saline did not result in a change in plasma somatostatin. It is concluded that peripheral circulating somatostatin may be susceptible to central nervous system control.

[1]  R. Unger,et al.  Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs. , 1981, Endocrinology.

[2]  R. Unger,et al.  Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs. , 1980, The Journal of clinical investigation.

[3]  J. Wass,et al.  CIRCULATING SOMATOSTATIN AFTER FOOD AND GLUCOSE IN MAN , 1980, Clinical endocrinology.

[4]  R. Unger,et al.  Gastric and Pancreatic Release of Somatostatin-like Immunoreactivity During the Gastric Phase of a Meal: Effects of Truncal Vagotomy and Atropine in the Anesthetized Dog , 1979, Diabetes.

[5]  G. Weir,et al.  Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. , 1979, The Journal of clinical investigation.

[6]  R. Unger,et al.  The response of plasma somatostatin-like immunoreactivity to nutrients in normal and alloxan diabetic dogs. , 1978, Endocrinology.

[7]  G. Weir,et al.  Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper- and hypoglycemic sulfonamides. , 1978, Metabolism: clinical and experimental.

[8]  K. Nagai,et al.  Central nervous system-mediated stimulation of glucagon secretion in the dog following 2-deoxyglucose. , 1976, Metabolism: clinical and experimental.

[9]  G. Sachs,et al.  Vagal gastric secretory stimulation by 2-deoxy-D-glucose. , 1965, The American journal of physiology.

[10]  A. Lazarow,et al.  Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.

[11]  S. Efendić,et al.  Vagal release of somatostatin into the antral lumen of cats. , 1977, Acta physiologica Scandinavica.

[12]  D. Porte,et al.  Neural regulation of insulin secretion in the dog. , 1973, The Journal of clinical investigation.

[13]  D. Cocchi,et al.  Central Nervous System Mediated Inhibition of Insulin Secretion Due to 2-Deoxyglucose* , 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.